Myeloid-Derived Suppressor Cells and Clinical Outcomes in Children With COVID-19

Myeloid-Derived Suppressor Cells and Clinical Outcomes in Children With COVID-19

BackgroundAlthough children with COVID-19 account for fewer hospitalizations than adults, many develop severe disease requiring intensive care treatment. Critical illness due to COVID-19 has been associated with lymphopenia and functional immune suppression. Myeloid-derived suppressor cells (MDSCs)...

Full description

Bibliographic Details
Main Authors:	Katherine Bline, Angel Andrews, Melissa Moore-Clingenpeel, Sara Mertz, Fang Ye, Victoria Best, Rouba Sayegh, Cristina Tomatis-Souverbielle, Ana M. Quintero, Zachary Maynard, Rebecca Glowinski, Asuncion Mejias, Octavio Ramilo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-06-01
Series:	Frontiers in Pediatrics
Subjects:	myeloid-derived suppressor cell (MDSC) pediatric COVID-19 respiratory disease T cell immune function
Online Access:	https://www.frontiersin.org/articles/10.3389/fped.2022.893045/full

Similar Items

New Perspectives on Myeloid-Derived Suppressor Cells and Their Emerging Role in Haematology
by: Nikoleta Bizymi, et al.
Published: (2022-09-01)

Staphylococcal Enterotoxins Dose-Dependently Modulate the Generation of Myeloid-Derived Suppressor Cells
by: Hartmut Stoll, et al.
Published: (2018-09-01)

The role of myeloid derived suppressor cells in musculoskeletal disorders
by: Yi Ren, et al.
Published: (2023-03-01)

Antibody-Mediated LILRB2-Receptor Antagonism Induces Human Myeloid-Derived Suppressor Cells to Kill Mycobacterium tuberculosis
by: Vipul K. Singh, et al.
Published: (2022-06-01)

Epigenetic targeting of myeloid-derived suppressor cells: time to move into infectious diseases?
by: Morten Frier Gjerstorff, et al.
Published: (2023-08-01)

A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment
by: Francesca Hofer, et al.
Published: (2021-10-01)

Human Isogenic Cell Line Models for Neutrophils and Myeloid-Derived Suppressor Cells
by: Yuting Zhang, et al.
Published: (2020-10-01)

The recent progress of myeloid‐derived suppressor cell and its targeted therapies in cancers
by: Ruiyang Ren, et al.
Published: (2023-08-01)

Evaluating Leukocyte Telomere Length and Myeloid-Derived Suppressor Cells as Biomarkers for Prostate Cancer
by: Haruhiko Wakita, et al.
Published: (2024-03-01)

B7H3-dependent myeloid-derived suppressor cell recruitment and activation in pulmonary fibrosis
by: Tianju Liu, et al.
Published: (2022-08-01)

Effect of pregnancy-specific β1-glycoprotein on myeloid-derived suppressor cell differentiation
by: V. P. Timganova, et al.
Published: (2023-06-01)

Myeloid-derived suppressor cells are associated with impaired Th1 and Th17 responses and severe pulmonary paracoccidioidomycosis which is reversed by anti-Gr1 therapy
by: Nycolas Willian Preite, et al.
Published: (2023-01-01)

How neutrophils shape adaptive immune responses.
by: Pieter eLeliefeld, et al.
Published: (2015-09-01)

The immune suppressive tumor microenvironment in multiple myeloma: The contribution of myeloid-derived suppressor cells
by: Claudia Giannotta, et al.
Published: (2023-01-01)

Defining the burden of respiratory syncytial virus infection
by: Asuncion Mejias, et al.
Published: (2013-11-01)

Extracellular vesicles released by cancer-associated fibroblast-induced myeloid-derived suppressor cells inhibit T-cell function
by: Carlo P. Ramil, et al.
Published: (2024-12-01)

Mast Cell Activation Triggered by Retrovirus Promotes Acute Viral Infection
by: Shu-Ting Song, et al.
Published: (2022-02-01)

Research progress of MDSCs-targeted immunotherapy for pancreatic cancer
by: QIN Yahan, et al.
Published: (2023-10-01)

Modified method for differentiation of myeloid-derived suppressor cells in vitro enhances immunosuppressive ability via glutathione metabolism
by: Haoyang Zhou, et al.
Published: (2023-03-01)

Increased Frequency of Myeloid-Derived Suppressor Cells in Myasthenia Gravis After Immunotherapy
by: Yan Wang, et al.
Published: (2022-06-01)

Integrated machine learning approaches for flow cytometric quantification of myeloid-derived suppressor cells in acute sepsis
by: Anthony S. Bonavia, et al.
Published: (2022-11-01)

Caveolin-1 Controls Vesicular TLR2 Expression, p38 Signaling and T Cell Suppression in BCG Infected Murine Monocytic Myeloid-Derived Suppressor Cells
by: Vini John, et al.
Published: (2019-12-01)

Deciphering the roles of myeloid derived suppressor cells in viral oncogenesis
by: Alexander Glover, et al.
Published: (2023-03-01)

Myeloid-Derived Suppressor Cells (MDSC) in the Umbilical Cord Blood: Biological Significance and Possible Therapeutic Applications
by: Nikoleta Bizymi, et al.
Published: (2022-01-01)

Expansion of myeloid-derived suppressor cells in the peripheral blood of patients with ankylosing spondylitis
by: A. Yu. Morenkova, et al.
Published: (2021-05-01)

Selective depletion of polymorphonuclear myeloid derived suppressor cells in tumor beds with near infrared photoimmunotherapy enhances host immune response
by: Takuya Kato, et al.
Published: (2022-12-01)

Crosstalk between interferon and interleukin-1 antiviral signaling in cancer cells: implications for immune evasion and therapeutic resistance
by: Morten Frier Gjerstorff, et al.
Published: (2023-06-01)

Specific circulating neutrophils subsets are present in clinically stable adults with cystic fibrosis and are further modulated by pulmonary exacerbations
by: Clémence Martin, et al.
Published: (2022-09-01)

PD-1/PD-L1, MDSC Pathways, and Checkpoint Inhibitor Therapy in <i>Ph</i>(-) Myeloproliferative Neoplasm: A Review
by: Jen-Chin Wang, et al.
Published: (2022-05-01)

(Im)maturity in Tumor Ecosystem
by: Keywan Mortezaee, et al.
Published: (2022-01-01)

Discovery of Myeloid-Derived Suppressor Cell-Specific Metabolism by Metabolomic and Lipidomic Profiling
by: Jisu Kim, et al.
Published: (2023-03-01)

Baseline Splenic Volume as a Prognostic Biomarker of FOLFIRI Efficacy and a Surrogate Marker of MDSC Accumulation in Metastatic Colorectal Carcinoma
by: Julie Niogret, et al.
Published: (2020-05-01)

Decoding the Myeloid-Derived Suppressor Cells in Lymphoid Malignancies
by: Iosif Papafragkos, et al.
Published: (2021-08-01)

Exosomes, MDSCs and Tregs: A new frontier for GVHD prevention and treatment
by: Nicholas J. Hess, et al.
Published: (2023-03-01)

Differences in SARS-CoV-2 Clinical Manifestations and Disease Severity in Children and Adolescents by Infecting Variant
by: Ana Maria Quintero, et al.
Published: (2022-11-01)

M-MDSC in vitro generation from mouse bone marrow with IL-3 reveals high expression and functional activity of arginase 1
by: Arpa Aintablian, et al.
Published: (2023-05-01)

Prognostic role of myeloid-derived suppressor cells in cancers: a systematic review and meta-analysis
by: Lisha Ai, et al.
Published: (2018-12-01)

Coordinated Regulation of Myeloid-Derived Suppressor Cells by Cytokines and Chemokines
by: Ru Li, et al.
Published: (2022-02-01)

Characterization of iNOS<sup>+</sup> Neutrophil-like ring cell in tumor-bearing mice
by: Virtuoso Lauren P, et al.
Published: (2012-07-01)

Myeloid-Derived Suppressor Cells and Mesenchymal Stem/Stromal Cells in Myeloid Malignancies
by: Suncica Kapor, et al.
Published: (2021-06-01)